Press releaseGlobe Newswire
Outlook Therapeutics
OTLK · NASDAQ
$0.52+$0.027 (+5.48%)TodayMarket closed ·
Prev close $0.493
Latest news
- Press releaseGlobe Newswire
Outlook Therapeutics Highlights What the Appointment of New CFO Kevin Lundquist Means for the Company’s Next Chapter in Virtual Investor Discussion
- Press releaseGlobe Newswire
Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)
- Press releaseGlobe Newswire
Outlook Therapeutics Fireside Chat from H.C. Wainwright Conference Now Available On-Demand
- Press releaseGlobe Newswire
Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment
- Press releaseGlobe Newswire
Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™
- Press releaseGlobe Newswire
Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
- NewsAvi Kapoor
5 Stocks In The Spotlight Last Week: Wall Street's Most Accurate Analysts Weigh In
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
Transcript: Outlook Therapeutics Q3 2026 Earnings Conference Call
- Press releaseGlobe Newswire
Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™
- NewsAvi Kapoor
S&P 500 Hits New Record High Following PPI Data: Investor Sentiment Improves, Fear Index Remains In ‘Greed’ Zone
- NewsAvi Kapoor
Outlook Therapeutics Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsVandana Singh
Outlook Therapeutics Targets Multibillion Dollar Ophthalmology Market With New Drug After FDA Rejection
- Press releaseGlobe Newswire
Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
- NewsVandana Singh
Outlook Therapeutics Eye Drug Review Returns To FDA For Fourth Time
- Press releaseGlobe Newswire
Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsDylan Berman
Outlook Shares Jump Following FDA Appeal Decision For LYTENAVA
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- NewsVandana Singh
Outlook Therapeutics Files FDA Resolution Request After Rejection For Vision Loss Drug
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Crude Oil Gains Around 4%; US Business Activity Declines In March
- NewsAvi Kapoor
Dow Falls Over 350 Points; Core & Main Posts Mixed Q4 Results
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- NewsAvi Kapoor
Dow Jumps Over 300 Points On First Trading Day Of 2026: Fear & Greed Index Remains In 'Neutral Zone
- NewsAvi Kapoor
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- NewsAvi Kapoor
Crude Oil Falls 1%; US Manufacturing Growth Eases In December
- NewsAvi Kapoor
US Stocks Mixed; Dow Falls Over 100 Points
- NewsVandana Singh
Outlook Therapeutics Stock Sinks After FDA Rejects Eye Drug Again
- NewsAvi Kapoor
Outlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Apple, Taiwan Semiconductor Manufacturing And 3 Stocks To Watch Heading Into Friday (CORRECTED)
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Nasdaq Surges 100 Points; Dollar General Earnings Beat Views
- NewsVandana Singh
FDA Rejects Outlook Therapeutics Eye Drug For Second Time
- NewsAvi Kapoor
US Stocks Mixed; Nvidia Posts Upbeat Earnings
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
- Press releaseGlobe Newswire
Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.